Literature DB >> 25225252

CrossTalk opposing view: Which technique for controlling resistant hypertension? Renal nerve ablation.

Markus P Schlaich1, Yusuke Sata2, Murray D Esler3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25225252      PMCID： PMC4198000          DOI： 10.1113/jphysiol.2014.270710

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  29 in total

1.  Splanchnicectomy for essential hypertension; results in 1,266 cases.

Authors:  R H SMITHWICK; J E THOMPSON
Journal:  J Am Med Assoc       Date:  1953-08-15

Review 2.  Physiology in perspective: The Wisdom of the Body. Neural control of the kidney.

Authors:  Gerald F DiBona
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09       Impact factor: 3.619

Review 3.  Neurogenic factors and hypertension in renal disease.

Authors:  V M Campese
Journal:  Kidney Int Suppl       Date:  2000-04       Impact factor: 10.545

4.  A limited renal injury may cause a permanent form of neurogenic hypertension.

Authors:  S Ye; M Gamburd; P Mozayeni; M Koss; V M Campese
Journal:  Am J Hypertens       Date:  1998-06       Impact factor: 2.689

Review 5.  Neural control of renal function.

Authors:  G F DiBona; U C Kopp
Journal:  Physiol Rev       Date:  1997-01       Impact factor: 37.312

6.  Renal denervation attenuates the sodium retention and hypertension associated with obesity.

Authors:  S Kassab; T Kato; F C Wilkins; R Chen; J E Hall; J P Granger
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

7.  Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.

Authors:  Shaohua Ye; Huiqin Zhong; Vijay Yanamadala; Vito M Campese
Journal:  Am J Hypertens       Date:  2002-08       Impact factor: 2.689

8.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

9.  Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.

Authors:  Markus P Schlaich; Elisabeth Lambert; David M Kaye; Zygmunt Krozowski; Duncan J Campbell; Gavin Lambert; Jacqui Hastings; Anuradha Aggarwal; Murray D Esler
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

10.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245
View more
  3 in total

1.  Rebuttal from Jens Jordan.

Authors:  Jens Jordan
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

2.  Rebuttal from L. E. K. Ratcliffe, W. Pijacka, F. D. McBryde, A. P. Abdala, D. J. Moraes, P. A. Sobotka, E. C. Hart, K. Narkiewicz, A. K. Nightingale and J. F. R. Paton.

Authors:  L E K Ratcliffe; W Pijacka; F D McBryde; A P Abdala; D J Moraes; P A Sobotka; E C Hart; K Narkiewicz; A K Nightingale; J F R Paton
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

Review 3.  Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension.

Authors:  Yusuke Sata; Geoffrey A Head; Kate Denton; Clive N May; Markus P Schlaich
Journal:  Front Med (Lausanne)       Date:  2018-03-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.